Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C - PubMed (original) (raw)
. 1997 Jun 12;14(23):2817-24.
doi: 10.1038/sj.onc.1201127.
Affiliations
- PMID: 9190898
- DOI: 10.1038/sj.onc.1201127
Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C
M Fichter et al. Oncogene. 1997.
Abstract
With respect to a potential role for CD44 in neuronal tumors, we investigated the regulation of variant CD44 exon containing isoforms (CD44V) in the human neuroblastoma cell line SK-N-SH in response to treatment with differentiation-inducing and mitogenic factors. While the standard form of CD44 was expressed at high levels in both treated and untreated cells, variant isoforms were strongly upregulated in response to treatment with 12-O-tetradecanoyl phorbol-13-acetate (TPA), insulin-like growth factor-1 (IGF-1) and platelet-derived growth factor (PDGF) as shown by RT-PCR and immunofluorescence. One of the CD44 isoforms contains sequences encoded by variant exon v6 (CD44V6), which was originally described as a metastasis-associated antigen. Using specific inhibitors, we explored the signal transduction pathways involved in the expression of variant CD44. GF-109203X, a specific inhibitor of protein kinase C effectively blocked TPA- and IGF-1-upregulated expression of CD44v6. Wortmannin, a specific inhibitor of phosphoinositide 3-kinase (PI 3-kinase) partly reduced IGF-1 and PDGF induced CD44v6 expression. The induction of CD44V by TPA, IGF-1 or PDGF was correlated with an increased cellular binding to hyaluronic acid, a major counterreceptor for CD44. The increased binding caused by TPA or IGF-1 could specifically be blocked by the above inhibitors. Thus, PKC and PI 3-kinase are likely to transduce growth factor induced signals that upregulate specific CD44 splice variants.
Similar articles
- Protein kinase C-epsilon is implicated in neurite outgrowth in differentiating human neuroblastoma cells.
Fagerström S, Påhlman S, Gestblom C, Nånberg E. Fagerström S, et al. Cell Growth Differ. 1996 Jun;7(6):775-85. Cell Growth Differ. 1996. PMID: 8780891 - The selective protein kinase C inhibitor GF 109203X inhibits phorbol ester-induced morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
Heikkilä J, Jalava A, Eriksson K. Heikkilä J, et al. Biochem Biophys Res Commun. 1993 Dec 30;197(3):1185-93. doi: 10.1006/bbrc.1993.2602. Biochem Biophys Res Commun. 1993. PMID: 8280132 - Differentiation and survival influences of growth factors in human neuroblastoma.
Påhlman S, Hoehner JC, Nånberg E, Hedborg F, Fagerström S, Gestblom C, Johansson I, Larsson U, Lavenius E, Ortoft E, et al. Påhlman S, et al. Eur J Cancer. 1995;31A(4):453-8. doi: 10.1016/0959-8049(95)00033-f. Eur J Cancer. 1995. PMID: 7576944 Review. - Proteolytic Processing of CD44 and Its Implications in Cancer.
Medrano-González PA, Rivera-Ramírez O, Montaño LF, Rendón-Huerta EP. Medrano-González PA, et al. Stem Cells Int. 2021 Jan 6;2021:6667735. doi: 10.1155/2021/6667735. eCollection 2021. Stem Cells Int. 2021. PMID: 33505471 Free PMC article. Review.
Cited by
- The Extracellular Matrix and Neuroblastoma Cell Communication-A Complex Interplay and Its Therapeutic Implications.
Horwacik I. Horwacik I. Cells. 2022 Oct 10;11(19):3172. doi: 10.3390/cells11193172. Cells. 2022. PMID: 36231134 Free PMC article. Review. - Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL, Hsu WM, Huang MC, Kadomatsu K, Nakagawara A. Ho WL, et al. J Hematol Oncol. 2016 Sep 29;9(1):100. doi: 10.1186/s13045-016-0334-6. J Hematol Oncol. 2016. PMID: 27686492 Free PMC article. Review. - Mechano-regulation of alternative splicing.
Liu H, Tang L. Liu H, et al. Curr Genomics. 2013 Mar;14(1):49-55. doi: 10.2174/138920213804999156. Curr Genomics. 2013. PMID: 23997650 Free PMC article. - Inhibition of glycogen synthase kinase-3 increases the cytotoxicity of enzastaurin.
Rovedo MA, Krett NL, Rosen ST. Rovedo MA, et al. J Invest Dermatol. 2011 Jul;131(7):1442-9. doi: 10.1038/jid.2011.70. Epub 2011 Apr 7. J Invest Dermatol. 2011. PMID: 21471986 Free PMC article. - Neuroblastoma cells negative for CD44 possess tumor-initiating properties.
Siapati EK, Rouka E, Kyriakou D, Vassilopoulos G. Siapati EK, et al. Cell Oncol (Dordr). 2011 Jun;34(3):189-97. doi: 10.1007/s13402-011-0022-z. Epub 2011 Mar 22. Cell Oncol (Dordr). 2011. PMID: 21424816
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous